专题：Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

This cluster of papers focuses on the diagnosis, management, and pathogenesis of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It covers evidence-based guidelines, cellular and molecular mechanisms of fibrosis, therapeutic translation, treatment trials with drugs like pirfenidone and nintedanib, as well as the role of myofibroblasts and epithelial-mesenchymal transition in lung fibrosis.
最新文献
Fleischner Society: Glossary of Terms for Thoracic Imaging

review Full Text OpenAlex

CT Honeycombing and Traction Bronchiectasis Extent Independently Predict Survival across Fibrotic Interstitial Lung Disease Subtypes

article Full Text OpenAlex

Emerging roles of noncoding RNAs in idiopathic pulmonary fibrosis

review Full Text OpenAlex

Indole-3-acetic acid attenuates pulmonary fibrosis by modulating lung microbiota, inhibiting fibroblast activation, and alleviating alveolar epithelial cell senescence

article Full Text OpenAlex

Loss of interferon regulatory factor-1 prevents lung fibrosis by upregulation of pon1 expression

article Full Text OpenAlex

Computed tomography morphological assessments of central airways in interstitial lung abnormalities and idiopathic pulmonary fibrosis

article Full Text OpenAlex

Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions

review Full Text OpenAlex

Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis

article Full Text OpenAlex

Nationwide Cross-Sectional Analysis of Mortality Trends in Patients with Sarcoidosis and Non-Ischemic Cardiovascular Disease—The Impact of Gender, Ethnicity, Geographical Location, and COVID-19 Pandemic

article Full Text OpenAlex

AIE nanoparticle with enhanced fluorescence for ultrasensitive lateral flow immunoassays and point-of-care diagnosis of interstitial lung disease

article Full Text OpenAlex

近5年高被引文献
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

article Full Text OpenAlex 2166 FWCI446.67871315

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

article Full Text OpenAlex 1104 FWCI160.95464969

Fibroblasts: Origins, definitions, and functions in health and disease

review Full Text OpenAlex 931 FWCI110.36890264

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation

article Full Text OpenAlex 650 FWCI121.53800023

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis

review Full Text OpenAlex 638 FWCI79.06233891

Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019

article Full Text OpenAlex 583 FWCI201.41286639

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

article Full Text OpenAlex 531 FWCI73.04864871

Global incidence and prevalence of idiopathic pulmonary fibrosis

review Full Text OpenAlex 515 FWCI64.38185988

ERS clinical practice guidelines on treatment of sarcoidosis

article Full Text OpenAlex 509 FWCI62.62163344

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

article Full Text OpenAlex 469 FWCI67.21183174